Correlation Between Immunome and Anixa Biosciences

Can any of the company-specific risk be diversified away by investing in both Immunome and Anixa Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Anixa Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immunome and Anixa Biosciences, you can compare the effects of market volatilities on Immunome and Anixa Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Anixa Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Anixa Biosciences.

Diversification Opportunities for Immunome and Anixa Biosciences

0.26

Correlation Coefficient

Immunome  Anixa Biosciences

Modest diversification

The 3 months correlation between Immunome and Anixa is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Anixa Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anixa Biosciences and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Anixa Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anixa Biosciences has no effect on the direction of Immunome i.e., Immunome and Anixa Biosciences go up and down completely randomly.

Pair Corralation between Immunome and Anixa Biosciences

Given the investment horizon of 90 days Immunome is expected to generate 1.11 times more return on investment than Anixa Biosciences. However, Immunome is 1.11 times more volatile than Anixa Biosciences. It trades about 0.02 of its potential returns per unit of risk. Anixa Biosciences is currently generating about 0.01 per unit of risk. If you would invest  1,404  in Immunome on September 3, 2024 and sell it today you would earn a total of  4.00  from holding Immunome or generate 0.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Immunome  vs.  Anixa Biosciences

Immunome

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Immunome are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Immunome may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Anixa Biosciences

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Anixa Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Anixa Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Immunome and Anixa Biosciences

The main advantage of trading using opposite Immunome and Anixa Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Anixa Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will offset losses from the drop in Anixa Biosciences' long position.

The idea behind Immunome and Anixa Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.